2-amino-3-methylimidazo(4,5-f)quinoline has been researched along with Chromosome-Defective Micronuclei in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abramsson-Zetterberg, L; Durling, LJ | 1 |
| Kiefer, F; Wiebel, FJ | 1 |
2 other study(ies) available for 2-amino-3-methylimidazo(4,5-f)quinoline and Chromosome-Defective Micronuclei
| Article | Year |
|---|---|
A comparison of genotoxicity between three common heterocyclic amines and acrylamide.
Topics: Acrylamide; Animals; Dose-Response Relationship, Drug; Erythrocytes; Heterocyclic Compounds; Imidazoles; Injections, Intraperitoneal; Male; Mice; Mice, Inbred BALB C; Micronuclei, Chromosome-Defective; Mutagens; Quinolines; Quinoxalines; Structure-Activity Relationship | 2005 |
Caffeine potentiates the formation of micronuclei caused by environmental chemical carcinogens in V79 Chinese hamster cells.
Topics: Aflatoxin B1; Animals; Anthracenes; Caffeine; Carcinogens, Environmental; Cells, Cultured; Cricetinae; Cricetulus; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP1A2; Drug Synergism; Fibroblasts; Methylnitronitrosoguanidine; Micronuclei, Chromosome-Defective; Mutagens; Nitrosamines; Pyrenes; Quinolines | 1998 |